We are live on ! Find out more
OXFD

Oxford Immunotec Global PLC Ordinary Shares
OXFD

Delisted

OXFD was delisted on the 5th of March, 2021.

Back to rankings

79 hedge funds and large institutions have $385M invested in Oxford Immunotec Global PLC Ordinary Shares in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 33 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

13% more capital invested

Capital invested by funds: $340M → $385M (+$45.2M)

5% more funds holding

Funds holding: 75 → 79 (+4)

18% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 33

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
79
Holders Change
+4
Holders Change %
+5.33%
% of All Funds
1.97%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
8
Increased
27
Reduced
33
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$13.2M
2
PA
Perceptive Advisors
New York
+$6.86M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$6.74M
4
DCM
Driehaus Capital Management
Illinois
+$4.65M
5
PC
Polar Capital
United Kingdom
+$4.27M

Top Sellers

Rank Fund Capital Flow
1
RG
Redmile Group
California
-$1.7M
2
NLVP
New Leaf Venture Partners
New York
-$1.63M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.24M
4
SIM
Spark Investment Management
New York
-$1.06M
5
Neuberger Berman Group
Neuberger Berman Group
New York
-$439K
Name Holding Trade Value Shares
Change 		Change in
Stake
USAA
26
United Services Automobile Association
Texas
$2.73M – – –
SCM
27
Stonepine Capital Management
Oregon
$2.73M +$2.64M +162,286 New
PCM
28
Penn Capital Management
Pennsylvania
$2.67M -$339K -20,812 -12%
CCI
29
Columbus Circle Investors
$2.64M +$2.56M +157,123 New
EIM
30
Essex Investment Management
Massachusetts
$2.33M -$35.6K -2,188 -2%
EI
31
EAM Investors
California
$2.02M +$1.96M +120,397 New
SIM
32
Spark Investment Management
New York
$1.43M -$1.06M -65,370 -43%
TCIM
33
TIAA CREF Investment Management
New York
$1.43M +$143K +8,760 +12%
BC
34
Birchview Capital
Vermont
$1.3M +$163K +10,000 +15%
Neuberger Berman Group
35
Neuberger Berman Group
New York
$1.3M -$439K -27,000 -26%
Russell Investments Group
36
Russell Investments Group
United Kingdom
$1.18M +$28.5K +1,751 +3%
Vanguard Group
37
Vanguard Group
Pennsylvania
$1.18M +$16K +982 +1%
TA
38
Teachers Advisors
New York
$1.1M +$158K +9,684 +17%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.07M +$18.8K +1,157 +2%
KCM
40
Kornitzer Capital Management
Kansas
$1.01M – – –
NA
41
Neuburgh Advisers
California
$1M -$121K -7,412 -11%
SC
42
Scholtz & Company
Connecticut
$990K +$959K +58,925 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$973K +$579K +35,595 +160%
Geode Capital Management
44
Geode Capital Management
Massachusetts
$971K +$63K +3,868 +7%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$968K -$245K -15,030 -21%
AC
46
Ascend Capital
California
$868K +$841K +51,655 New
FCM
47
Flinton Capital Management
Pennsylvania
$823K -$99.3K -6,104 -11%
Charles Schwab
48
Charles Schwab
California
$681K – – –
KeyBank National Association
49
KeyBank National Association
Ohio
$676K -$244K -15,018 -27%
Wells Fargo
50
Wells Fargo
California
$651K +$150K +9,235 +31%
1
2
3 4

OXFD Hedge Fund Activity: Q3 2017 in Review

79 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Oxford Immunotec Global PLC Ordinary Shares (OXFD) for Q3 2017, worth a combined $385M — up 13% from $340M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new OXFD positions and 4 closed out — a net gain of 4 holders — while 27 added to existing stakes and 33 trimmed.

The largest buyer was Invesco, adding an estimated $13.2M. The largest seller was Redmile Group, cutting an estimated $1.7M.

  • 79 institutional investors held Oxford Immunotec Global PLC Ordinary Shares (OXFD) as of Q3 2017, up from 75 in Q2 2017.
  • Funds reported $385M of Oxford Immunotec Global PLC Ordinary Shares stock for Q3 2017, up 13% quarter-over-quarter.
  • 8 funds opened new Oxford Immunotec Global PLC Ordinary Shares positions in Q3 2017 and 4 closed out, a net change of +4 holders.
  • The largest Oxford Immunotec Global PLC Ordinary Shares buyer in Q3 2017 was Invesco, an estimated $13.2M added.
  • The largest Oxford Immunotec Global PLC Ordinary Shares seller in Q3 2017 was Redmile Group, an estimated $1.7M sold.

Based on aggregated 13F filings for Q3 2017.